Health
WHO calls for equitable access to future COVID-19 vaccines in Africa
|
|
|
The World Health Organization (WHO) in Africa joined immunization experts in urging the international community and countries in Africa to take concrete actions to ensure equitable access to COVID-19 vaccines, as researchers around the world race to find effective protection against the virus.“It is clear that as the international community comes together to develop safe and effective vaccines and therapeutics for COVID-19, equity must be a central focus of these efforts,” said Dr Matshidiso Moeti, WHO Regional Director for Africa. “Too often, African countries end up at the back of the queue for new technologies, including vaccines. These life-saving products must be available to everyone, not only those who can afford to pay.”
WHO and partners launched the Access to COVID-19 Tools (ACT) Accelerator to speed up the development, production and equitable access to COVID-19 diagnostics, therapeutics and vaccines. It brings together leaders of government, global health organizations civil society groups, businesses and philanthropies to form a plan for an equitable response to the COVID-19 pandemic. WHO is collaborating with Gavi, the Vaccine Alliance and the Coalition for Epidemic Preparedness Innovations (CEPI) to ensure a fair allocation of vaccines to all countries, aiming to deliver 2 billion doses globally for high-risk populations, including 1 billion for low and middle-income countries. The African Union has endorsed the need for Africa to develop a framework to actively engage in the development and access to COVID-19 vaccines. Countries can take steps now that will strengthen health systems, improve immunization delivery, and pave the way for the introduction of a COVID-19 vaccine. These include: mobilizing financial resources; strengthening local vaccine manufacturing, and regulatory, supply and distribution systems; building workforce skills and knowledge; enhancing outreach services; and listening to community concerns to counter misinformation. Globally, there are nearly 150 COVID-19 vaccine candidates and currently 19 are in clinical trials. South Africa is the first country on the continent to start a clinical trial with the University of Witwatersrand in Johannesburg testing a vaccine developed by the Oxford Jenner Institute in the United Kingdom. The South African Ox1Cov-19 Vaccine VIDA-Trial is expected to involve 2000 volunteers aged 18–65 years and include some people living with HIV. The vaccine is already undergoing trials in the United Kingdom and Brazil with thousands of participants. According to the African Academy of Sciences only 2% of clinical trials conducted worldwide occur in Africa. It is important to test the COVID-19 vaccine in countries where it is needed to ensure that it will be effective. With more than 215 000 cases, South Africa accounts for 43% of the continent’s total cases. Clinical trials must be performed according to international and national scientific and ethical standards, which include informed consent for any participant. “I encourage more countries in the region to join these trials so that the contexts and immune response of populations in Africa are factored in to studies,” said Dr Moeti. “Africa has the scientific expertise to contribute widely to the search for an effective COVID-19 vaccine. Indeed, our researchers have helped develop vaccines which provide protection against communicable diseases such as meningitis, Ebola, yellow fever and a number of other common health threats in the region.” Earlier, this month WHO Africa’s principle advisory group on immunization policies and programmes – the African Regional Immunization Technical Advisory Group (RITAG) – also noted the need to ensure equitable access to COVID-19 and other vaccines in the region. “As the world focuses on finding a vaccine for COVID-19, we must ensure people do not forget that dozens of lifesaving vaccines already exist. These vaccines should reach children everywhere in Africa – no one can be left behind,” said Professor Helen Rees, Chair of the RITAG. Initial analysis of the impact of the COVID-19 pandemic on immunization in the African Region suggests that millions of African children are likely to be negatively impacted, as routine immunization services and vaccination campaigns for polio, cholera, measles, yellow fever, meningitis and human papilloma virus have been disrupted. Despite these challenges, RITAG members also noted significant milestones and markers of progress. For example, there have been tremendous gains in the fight against wild poliovirus, and the African Region is expected to be officially certified free of wild poliovirus in August 2020. The Democratic Republic of the Congo also announced the end of its 10th Ebola outbreak in eastern DRC, which was the worst in its history. An effective vaccine was a key tool in the response. Dr Moeti spoke about COVID-19 vaccine development in Africa during a virtual press conference today organized by APO Group. She was joined by Professor Shabir Madhi, University of Witwatersrand, Principal Investigator of Oxford Covid-19 Vaccine Trial in South Africa; and Professor Pontiano Kaleebu, Director of the MCR/UVRI and LSHTM Ugandan Research Unit. The briefing was streamed on more than 300 African news sites as well as the WHO Regional Office for Africa’s Twitter and Facebook accounts. |
Resident doctors at the University of Medical Sciences Teaching Hospital (UNIMEDTH) in Ondo State have initiated a 14-day warning strike, as confirmed by the National Association of Resident Doctors (NARD).
The strike action, led by the association’s President, John Matthew, highlights various grievances, notably the non-payment of seven months’ salaries to new members.
Matthew added that the strike also addresses the non-payment of palliative to House Officers since February, the failure to disburse the February Hazard Allowance despite prior assurances from the state government, and the ongoing shortage of staff due to resignations.
Matthew lamented the drastic decrease in resident doctors, citing a decrease from 150 doctors to a mere 26 in recent months.
In response to the situation, he urged management to prioritise the full payment of arrears owed to members, immediate payment of the February 2024 palliative to house officers, and prompt disbursement of the February hazard allowance.
The association further called for urgent measures to address the critical shortage of clinical manpower within the institution.
The Federal Government has greenlit the allocation of N25 billion to bolster the efforts of the National Primary Healthcare Development Agency (NPHCDA) and the National Health Insurance Authority (NHIA) in advancing healthcare accessibility and quality across Nigeria.
The Coordinating Minister of Health and Social Welfare, Ali Pate, made this known, stressing the steadfast commitment of the current administration towards revamping the healthcare system to achieve Universal Healthcare Coverage (UHC) for all Nigerians.
In a statement by Deworitshe Patricia, a spokesperson for the ministry, Pate emphasised that the government’s strategy for health sector transformation involves the implementation of a Sector Wide Approach (SWAp) and the Health Sector Renewal Investment Programme (NHSRIP).
Addressing the imperative for reforms in Nigeria’s primary healthcare delivery, Pate highlighted the significance of revising the Basic Healthcare Provision Fund (BHCPF) and its associated programmes.
Pate outlined the objectives of the revised guidelines, which include expanding healthcare services for underserved populations, particularly women and children, reducing maternal mortality rates, alleviating out-of-pocket healthcare expenses, and standardizing healthcare quality across primary healthcare facilities nationwide.
“The Ministry, in collaboration with development partners, is dedicated to ensuring equitable access to healthcare services for all Nigerians, with a special focus on vulnerable groups,” stated Pate. “Through initiatives like NHSRIP, we aspire to minimize the need for long-distance travel for medical care, thereby improving the overall health outcomes and well-being of our citizens.”
In a monumental achievement for medical science, a team of Saudi professionals at the King Abdullah Specialist Children’s Hospital has completed the separation surgery of Nigerian conjoined twins, Hassana and Husaina.
The directive for this historic achievement came from the Custodian of the Two Holy Mosques King Salman bin Abdulaziz Al-Saud and His Royal Highness Prince Mohammed bin Salman bin Abdulaziz Al-Saud, Crown Prince and Prime Minister, demonstrating the Kingdom’s commitment to advancing healthcare.
The complex procedure, initiated on Thursday morning, was the result of meticulous planning and execution by a dedicated team of 38 medical experts. This group included consultants, specialists, technicians, and nursing staff, all working in harmony to address shared areas in the lower abdomen, pelvis, lower spine, and lower spinal nerves of the twins.
The surgery, unfolding in nine carefully planned stages, lasted approximately 14 hours. Dr. Abdullah Al Rabeeah, Advisor at the Royal Court, Supervisor General of the King Salman Humanitarian Aid and Relief Center (KSrelief), and head of the medical team, expressed confidence in the success of the procedure, citing a noteworthy 70% success rate.
“This is a momentous occasion that showcases the Kingdom’s commitment to advancing medical science and providing compassionate healthcare globally,” he said.
The successful separation of Hassana and Husaina commemorates the 60th operation conducted by the Saudi programme for separating conjoined twins. Over the past 34 years, this programme has offered care to 135 conjoined twins from 25 countries.
Dr. Al Rabeeah expressed heartfelt gratitude and appreciation to the Saudi leadership for their steadfast support of the programme.
He said, “The successful separation of Hassana and Husaina exemplifies the Kingdom’s dedication to humanitarian causes and its role as a leader in global healthcare.”
The Press Attaché at the Saudi embassy in Abuja, Mohammed Alsahabi, remarked on the accomplishment, stating, “This remarkable feat underscores the strong collaboration between Saudi Arabia and Nigeria in healthcare. We take pride in contributing to the improvement of these twins’ lives and their families.”
The separation of Hassana and Husaina represents not just a medical triumph but also serves as a symbol of hope for numerous individuals confronting similar challenges globally.
-
Politics3 days agoWhy Oyo State cannot afford another 3 years of Makinde’s mismanagement of council funds
-
Opinion3 days ago
Tinubu’s Naira Miracle: Abracadabra or Economic Wizardry? | By Adeniyi Olowofela
-
News1 week ago
FERMA House C’ttee Chair, Oseni Consoles Sen. Buhari over mum’s death
-
Politics1 week ago
APC Urges Fairness in Oyo LG Election
